NASDAQ:ALDX
Aldeyra Therapeutics Stock News
$3.77
-0.170 (-4.31%)
At Close: May 10, 2024
Aldeyra Therapeutics to Present at the Oppenheimer & Co. 30th Annual Healthcare Conference
01:00pm, Tuesday, 03'rd Mar 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated d
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
09:01pm, Thursday, 06'th Feb 2020
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2019, and provided an operating forecast and program updates. Ligand
